deltatrials

Non-small cell lung cancer Trials in Vallejo, United States

Conditions / Non-small cell lung cancer / Vallejo, United States

Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID Title Status Phase
NCT01137968 Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) COMPLETED PHASE2
NCT05899608 Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients RECRUITING
NCT03906331 Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation APPROVED_FOR_MARKETING
NCT07185997 Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations RECRUITING
NCT02486718 Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] ACTIVE_NOT_RECRUITING
NCT01493843 Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer COMPLETED PHASE2
NCT01903993 A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - POPLAR COMPLETED PHASE2
NCT07195695 Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment RECRUITING PHASE3
NCT05668988 A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) ACTIVE_NOT_RECRUITING PHASE3
NCT00858364 Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy TERMINATED PHASE3

Related Pages